UPMC Enterprises has contributed to a $117m series B round for gene therapy developer Ring Therapeutics.
PsiQuantum has become the first unicorn in Imec.xpand’s portfolio as it fetched a valuation of more than $3bn.
IP Group is among the investors backing the DDR cancer therapeutics developer’s latest round, which took its total funding to $320m.
SoftBank’s Vision Fund 2 has invested at a $2.7bn valuation, taking the Stanford-backed life insurance platform developer’s overall funding to over $400m.
ArcelorMittal led a series D round for the rechargeable battery developer spun out of MIT.
The NFT marketplace, which counts Stanford-StartX Fund as an investor, has raised series B funding led by Andreessen Horowitz.
The Oxford-backed corporate education resource provider’s overall funding now stands at more than $280m.
Several corporates helped the Montana State University-backed microbial protein developer take its total funding above $500m.
WUSTL spinout Wugen has collected $172m in a series B round to progress its pipeline targeting several cancer indications.
The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.